Naronapride dihydrochloride

N/A

Report date: 2024/03/29 14:52:12
NME

Base Information

Drug NameNaronapride dihydrochloride
Drug Alias NameNaronaprideATI-7505
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor agonistsDopamine D2 receptor antagonists
TargetsSerotonin 4 (5-HT4) receptorDopamine D2 receptor
Therapy Area/IndicationsHeartburnDyspepsiaConstipation +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRenexxion LLCAryx Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDr. Falk Pharma GmbHDr Falk Pharma GmbHRenexxion LLC +[4] 
Inactive CompaniesAryx Therapeutics IncProcter & Gamble Company
Active IndicationsHeartburnGastroparesisGastroesophageal Reflux
Inactive IndicationsDyspepsiaConstipation

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG